Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
Conditions
- Diabetes Mellitus, Type 2
- NASH - Nonalcoholic Steatohepatitis
Interventions
- DRUG: dulaglutide (TRULICITY®) 1.5 mg
- OTHER: reinforced dietary monitoring
Sponsor
Central Hospital, Nancy, France
Collaborators